Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model.
Molecules
; 26(12)2021 06 19.
Article
in En
| MEDLINE
| ID: mdl-34205347
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urologic Neoplasms
/
Receptors, OX40
/
Programmed Cell Death 1 Receptor
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Molecules
Journal subject:
BIOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
United States
Country of publication:
Switzerland